Results 171 to 180 of about 576,050 (220)

Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies. [PDF]

open access: yesMol Oncol
Ojala VK   +15 more
europepmc   +1 more source

The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation. [PDF]

open access: yesJ Neuroinflammation
Gryksa K   +4 more
europepmc   +1 more source

Combination AURKA and WEE1 Inhibition Exhibits Efficacy in EGFR or Pan-ERBB Inhibitor-Resistant Head and Neck Squamous Cell Carcinoma. [PDF]

open access: yesCancer Res Commun
Silva FN   +7 more
europepmc   +1 more source

Immune responses to all ErbB family receptors detectable in serum of cancer patients

open access: yesOncogene, 1999
Employing NIH3T3 transfectants with individual human ErbB receptor coding sequences as recombinant antigen sources, we detected by immunoblot analysis specific immunoreactivity against all four ErbB receptors among 13 of 41 sera obtained from patients ...
Vincenzo Visco   +2 more
exaly   +2 more sources

ErbB receptors and tetraspanins: Casting the net wider [PDF]

open access: yesInternational Journal of Biochemistry and Cell Biology, 2016
Fedor Berditchevski
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

ErbB receptors and their ligands in the breast

Expert Reviews in Molecular Medicine, 2006
ErbB receptor tyrosine kinases are membrane-bound receptors that possess intrinsic, ligand-activated, tyrosine kinase activity. Binding of growth factors to these receptors induces the formation of ErbB homo- and heterodimers and initiates a signalling cascade that traverses the cytoplasm to communicate with the nucleus and the cytoskeleton. The effect
openaire   +2 more sources

Home - About - Disclaimer - Privacy